**Core Concept**
Tumor lysis syndrome (TLS) is a life-threatening condition that occurs when a large number of cancer cells die rapidly, releasing their contents into the bloodstream. This can lead to hyperkalemia, hyperphosphatemia, hypocalcemia, and acute kidney injury.

**Why the Correct Answer is Right**
TLS is characterized by the breakdown of cancer cells, which leads to the release of intracellular contents, including potassium, phosphate, and nucleic acids. The kidneys are unable to filter these substances effectively, resulting in their accumulation in the blood. The hyperphosphatemia can lead to hypocalcemia as phosphate binds to calcium, forming insoluble calcium phosphate complexes. The hyperkalemia can lead to cardiac arrhythmias and cardiac arrest.

**Why Each Wrong Option is Incorrect**
**Option A:** Hyperuricemia - While TLS can lead to hyperuricemia due to the breakdown of nucleic acids, this is a common occurrence in TLS and not an exception.

**Option B:** Hyperkalemia - As mentioned earlier, hyperkalemia is a hallmark of TLS due to the release of potassium from dying cancer cells.

**Option C:** Hyperphosphatemia - Similar to hyperkalemia, hyperphosphatemia is a common occurrence in TLS due to the release of phosphate from dying cancer cells.

**Clinical Pearl / High-Yield Fact**
The 5 Ps of TLS are: **P**otassium, **P**hosphate, **P**urine, **P**rotactin, and **P**eritoneal effusion. Remembering these Ps can help you diagnose and manage TLS.

**Correct Answer: None**